. Scientific Frontline: Bone Marrow Transplants and Human Immune Recovery

Tuesday, November 17, 2026

Bone Marrow Transplants and Human Immune Recovery

Study authors Rong Lu, PhD, and Mary Vergel Snodgrass in the lab.
Photo Credit: Chris Shinn

Scientific Frontline: Extended "At a Glance" Summary
: Pre-Transplant Conditioning and Immune Recovery

The Core Concept: A study utilizing genetic barcoding to track individual human blood-forming cells in mice reveals how pre-transplant conditioning treatments, such as radiation or chemotherapy, shape the regeneration of the blood and immune systems.

Key Distinction/Mechanism: By comparing hematopoietic stem cells (HSCs) and multipotent progenitor cells (MPPs) through clonal tracking, researchers discovered that human MPPs possess a greater long-term regenerative capacity than previously observed in mouse models, while HSCs offer more consistent blood cell production across varying transplantation conditions.

Origin/History: Led by Rong Lu, PhD, and Mary Vergel Snodgrass at the Keck School of Medicine of USC, the findings were published in npj Regenerative Medicine in November 2026.

Major Frameworks/Components:

  • Genetic barcode-based clonal tracking to monitor the specific lineages of individual cells over time.
  • Comparative analysis of regenerative capacities between human HSCs and MPPs in an in vivo environment.
  • Evaluation of pre-transplant conditioning regimens, specifically contrasting radiation therapy, busulfan chemotherapy, and no conditioning.
  • Observation of extramedullary hematopoiesis, noting substantial blood cell production in the spleen during secondary transplants.

Branches of Science: Stem Cell Biology, Regenerative Medicine, Hematology, Immunology, Molecular Genetics.

Future Application: The insights gained can support the development of highly personalized pre-transplant conditioning regimens for patients undergoing treatment for inherited blood disorders, leukemia, and lymphoma.

Why It Matters: By identifying distinct behavioral differences between human and mouse stem cells, this research establishes critical benchmarks for optimizing bone marrow transplants, aiming to maximize immune recovery while minimizing treatment-related complications.

Using genetic barcoding to track individual human blood-forming cells in mice, USC researchers reveal how chemotherapy and radiation influence the regeneration of blood and immune cells, with implications for preclinical research and bone marrow transplantation strategies for patients with blood cancer and other disorders.

In a new study from the USC Stem Cell lab of Rong Lu, PhD, researchers used genetic barcoding to track individual human blood-forming stem and progenitor cells after transplanting them into mice. The study revealed how distinct types of human blood-forming cells regenerate the blood and immune systems, and how various pre-transplant conditioning regimens affected blood and immune cell recovery. The findings, just published in npj Regenerative Medicine, add to the scientific understanding of human blood and immune cell regeneration and can inform future strategies to optimize bone marrow transplants for patients.

Researchers used genetic barcode-based clonal tracking, which allows them to follow individual cells and their descendants to see how they contribute to blood and immune cell production over time, comparing two cell types: hematopoietic stem cells (HSCs) and multipotent progenitor cells (MPPs). While both HSCs and MPPs can produce multiple types of blood and immune cells, earlier animal models established the paradigm that HSCs possess a unique long-term regenerative capacity.

“We found that human HSCs and MPPs don’t always behave as we would expect based on previous studies in mice,” said Rong Lu, PhD, professor of stem cell biology and regenerative medicine at the Keck School of Medicine of USC, who led the research. She is also a professor of biomedical engineering, medicine, and gerontology. “Our findings underscore the importance of studying human cells directly to understand how they function in the context of transplantation.”

The study, supported by the National Institutes of Health, is one of the first to systematically examine how human HSCs and MPPs respond to various forms of pre-transplant conditioning, including chemotherapy and radiation, and contribute to the production of blood and immune cells. Down the line, it could support the development of more effective and personalized approaches to bone marrow transplantation, which is used to treat blood cancers, such as leukemia and lymphoma, and certain inherited blood disorders.

Stem Cells and Transplant Treatments

For the study, first author Mary Vergel Snodgrass and her colleagues transplanted human HSCs or MPPs into mice, then used clonal tracking to compare how the two cell populations contributed to blood and immune cell production over time.

They found that both HSCs and MPPs produced multiple types of blood and immune cells over an extended period after transplantation, suggesting that human MPPs may have greater long-term regenerative capacity than previously observed in mouse studies. However, HSCs generally produced more blood cells and were better at producing multiple types of blood and immune cells than MPPs. The researchers also compared several approaches to transplant conditioning, which depletes the recipient's endogenous stem and progenitor cells to facilitate donor cell engraftment. Mice received either radiation treatment, chemotherapy with the drug busulfan, or no conditioning treatment. The conditioning approach influenced how many and which types of blood and immune cells were produced, and how quickly blood cell production occurred, without significantly affecting donor cell engraftment in the bone marrow.

“We also found that HSCs were less affected by conditioning, while MPPs were more sensitive, shifting the types of immune cells they produced. This suggests that human HSCs can maintain more consistent blood and immune cell production under different transplantation conditions,” Lu said.

These findings could eventually help clinicians tailor pre-transplant treatments to individual patients, supporting more effective blood and immune cell recovery while minimizing treatment-related complications. While further studies are needed to determine how these findings translate to patients, they could help guide the development of safer and more effective transplantation strategies.

New Insights into Human Blood Cell Regeneration

In a final experiment, the researchers transplanted HSCs and MPPs from the initial recipients into a second group of mice to test their long-term regenerative capacity. They found that both cell types continued producing blood and immune cells, but at substantially lower levels.

The secondary transplant cohort also exhibited extramedullary hematopoiesis; blood cell production occurred in tissues outside the bone marrow, notably resulting in substantial splenomegaly. Lu noted that this phenomenon has also been observed in human diseases and may indicate that the mouse bone marrow environment does not fully support human blood cell production.

Future research will investigate the cellular signaling mechanisms between hematopoietic stem cells and the surrounding bone marrow microenvironment to understand how these interactions regulate blood and immune cell regeneration. This work could help explain why different conditioning treatments lead to different patterns of blood and immune cell recovery.

Funding: This work was supported by the National Institutes of Health (grant R35HL150826). Additional support came from a USC Provost’s Fellowship, a California Institute for Regenerative Medicine training grant (EDUC4-12756), and a Leukemia & Lymphoma Society scholarship (LLS-1370-20).

Published in journal: npj Regenerative Medicine

Title: Tracking human HSCs and MPPs in mice reveals distinct clonal dynamics and responses to pre-transplant conditioning

Authors: Mary Vergel Snodgrass, Jiya Eerdeng, Patrick Condie, Basia Gala, and Rong Lu

Source/Credit: University of Southern California, Keck School of Medicine | BY  Zara Abrams

Edited by: Scientific Frontline

Reference Number: cbio111726_01

Privacy Policy | Terms of Service | Contact Us

Featured Article

What Is: The Minimal Genome and Synthetic Evolution

Scientific Frontline: Extended "At a Glance" Summary : The Minimal Genome and Synthetic Evolution The Core Concept : Researchers h...

Top Viewed Articles